VEGFA and hepatocellular carcinoma: Transcatheter arterial chemoembolization (TACE) in combination with thalidomide-mediated adjuvant treatment has demonstrated a promising clinical outcome in hepatocellular carcinoma (HCC) patients by lowering VEGF levels [41].